Infinity Pharmaceuticals, Inc. Financial Ratios — INFIQ

Profitability (USD)

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Return on Common Equity (%)	27.6	-29.7	-70.08	-123.36	-33.14	-49.57	-8.48	-83.35	-33.26	-64.26	-22.46	-156.37	- -	- -	- -
Return on Assets (%)	16.29	-19.68	-34.75	-32.16	-23.45	-44.77	-5.81	-39.02	-14.52	-45.22	-18.82	-86.16	-91.68	-72.94	-69.91
Return on Capital (%)	27.55	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	22.27	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	- -	100	100	100	100	99.69	-139.69	39.67	39.72	39.72
EBITDA Margin (%)	25.3	-87.45	-64.56	-39.27	-207	- -	-3.73	-114.44	-746.08	-578.83	-53	-1,490.49	-2,211.4	-2,400.59	-1,711.76
Operating Margin (%)	22.94	-91.69	-67.62	-41.53	-210.49	- -	-4.8	-116.54	-764.34	-607.42	-53.87	-1,497.67	-2,239.5	-2,426.43	-1,729.43
Incremental Operating Margin (%)	72.03	- -	- -	- -	- -	60.5	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	28.35	-62.26	-69.65	-43.16	-114.54	- -	-10.44	-117.4	-160.77	-709.17	-50.81	-1,545.13	-2,355.56	-2,436.06	-1,711.11
Profit Margin (%)	28.35	-61.61	-68.67	-43.16	-114.54	- -	-10.56	-117.7	-160.77	-697.17	-50.81	-1,543.36	-2,355.56	-2,436.06	-1,711.11
Net Income to Common Margin (%)	28.35	-61.61	-68.67	-43.16	-114.54	- -	-10.56	-117.7	-160.77	-697.17	-50.81	-1,543.36	-2,355.56	-2,436.06	-1,711.11
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	27.6	-29.7	-70.08	-123.36	-33.14	-49.57	-8.48	-83.35	-33.26	-64.26	-22.46	-156.37	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Total Debt	- -	- -	- -	38	- -	7	15	20	20	6	- -	2	23	1	1
ST Debt	- -	- -	- -	- -	- -	7	- -	- -	- -	6	- -	- -	- -	1	1
LT Debt	- -	- -	- -	38	- -	- -	15	20	19	- -	- -	2	23	1	- -
Total Debt/EBITDA	- -	- -	- -	-1.03	- -	-0.05	-2.51	-0.16	-0.14	-0.17	- -	-0.05	-0.62	-0.03	-0.02
Net Debt/EBITDA	-0.79	0.37	0.44	-0.37	1.8	0.44	49.98	1.51	0.53	0.82	4.14	-0.16	0.16	0.7	0.86
Total Debt/EBIT	- -	- -	- -	-0.97	- -	-0.05	-1.95	-0.16	-0.14	-0.16	- -	-0.05	-0.61	-0.03	-0.02
Net Debt/EBIT	-0.87	0.35	0.42	-0.35	1.77	0.43	38.8	1.48	0.52	0.78	4.08	-0.16	0.16	0.69	0.85
EBITDA to Interest Expense	987.91	-34.14	-24.11	-19.79	-51.11	- -	-0.64	-91.24	-114.03	-34.39	-126.22	-17.73	-15.55	-247.79	-246.59
EBITDA-CapEx/Interest Expense	922.75	-36.09	-25.13	-20.63	-51.8	- -	-0.78	-95.94	-114.57	-34.43	-126.22	-18.64	-15.57	-247.86	-246.68
EBIT to Interest Expense	895.62	-35.8	-25.25	-20.93	-51.98	- -	-0.82	-92.92	-116.82	-36.08	-128.27	-17.82	-15.75	-250.46	-249.13
Interest Expense	- -	1	2	2	2	- -	10	1	1	1	- -	3	2	- -	- -
Common Equity/Total Assets	74.9	57.41	39.72	12.4	92.42	87.24	56.75	34.12	65.62	80.42	87.12	15.76	-58.47	25.44	-45.2
Long-Term Debt/Equity (%)	0.01	0.01	- -	243.33	- -	- -	7.38	19.88	23.22	- -	- -	24.93	- -	4.25	- -
Long-Term Debt/Capital (%)	0.01	0.01	- -	70.87	- -	- -	6.87	16.52	18.77	- -	- -	19.2	4,645.45	3.99	-1.79
Long-Term Debt/Total Assets (%)	0.01	- -	- -	30.17	- -	- -	4.19	6.78	15.24	- -	- -	3.93	58.48	1.08	0.77
Total Debt/Equity (%)	0.01	0.01	- -	243.33	- -	3.31	7.38	20.3	23.76	12.57	- -	29.86	-102.15	6.66	-4.81
Total Debt/Capital (%)	0.01	0.01	- -	70.87	- -	3.21	6.87	16.87	19.2	11.17	- -	22.99	4,744.24	6.24	-5.06
Total Debt/Total Assets (%)	0.01	0.01	- -	30.17	- -	2.89	4.19	6.93	15.59	10.11	- -	4.71	59.73	1.69	2.18
Net Debt to Equity	-13.78	-18.03	-41.26	86.54	-56.65	-27.32	-146.75	-190.93	-89.82	-59.94	-92.67	95.34	26.91	-144.18	201.11
Net Debt/Capital (%)	-15.98	-22	-70.24	46.39	-130.7	-39.33	372.72	270.34	-264.64	-149.59	-1,265.05	-60.24	22.02	53.89	67.87
EBITDA	21	-44	-46	-36	-98	-126	-6	-125	-140	-35	-12	-45	-38	-45	-44
EBITDA-CapEx	20	-47	-48	-38	-99	-128	-8	-131	-140	-35	-12	-48	-38	-45	-44
Operating Income (Loss)	19	-47	-48	-39	-99	-128	-8	-127	-143	-36	-12	-46	-38	-45	-45

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Cash Ratio	7.91	9.16	3.61	3.98	17.47	9.63	6.06	3.5	3.86	4.97	7.59	4.38	3.09	6.07	2.81
Current Ratio	8.52	9.41	3.72	4.07	17.67	10.13	6.28	3.64	4.26	5.04	7.75	4.6	3.26	6.19	2.96
Quick Ratio	8.37	9.16	3.61	3.98	17.47	9.63	6.11	3.52	3.86	4.97	7.59	4.38	3.09	6.07	2.81
CFO/Avg Current Liab	-0.51	-0.31	-1.27	-1.17	-3.36	-5.57	3.05	-1.34	-3.29	-2.07	-0.49	-4.77	-3.45	-3.34	-3.15
Common Equity/Total Assets	74.9	57.41	39.72	12.4	92.42	87.24	56.75	34.12	65.62	80.42	87.12	15.76	-58.47	25.44	-45.2
Long-Term Debt/Equity (%)	0.01	0.01	- -	243.33	- -	- -	7.38	19.88	23.22	- -	- -	24.93	- -	4.25	- -
Long-Term Debt/Capital (%)	0.01	0.01	- -	70.87	- -	- -	6.87	16.52	18.77	- -	- -	19.2	4,645.45	3.99	-1.79
Long-Term Debt/Total Assets (%)	0.01	- -	- -	30.17	- -	- -	4.19	6.78	15.24	- -	- -	3.93	58.48	1.08	0.77
Total Debt/Equity (%)	0.01	0.01	- -	243.33	- -	3.31	7.38	20.3	23.76	12.57	- -	29.86	-102.15	6.66	-4.81
Total Debt/Capital (%)	0.01	0.01	- -	70.87	- -	3.21	6.87	16.87	19.2	11.17	- -	22.99	4,744.24	6.24	-5.06
Total Debt/Total Assets (%)	0.01	0.01	- -	30.17	- -	2.89	4.19	6.93	15.59	10.11	- -	4.71	59.73	1.69	2.18
CFO/Total Liabilities	-25.85	-7.1	-35.41	-30.36	-314.81	-386.98	73.72	-43.97	-357.3	-315.85	-60.78	-100.59	-57.36	-64.25	-69.33
CFO/CapEx	-7.49	-1.88	-13.64	-21.47	-61.59	-64.94	86.43	-13.02	-233.52	-853.74	- -	-17.85	-831.14	-3,692.55	-2,495.94
Altman's Z-Score	3.62	0.11	-1.3	-1.14	38.12	10.08	2.65	-1.97	-8.89	-11.41	-9.83	-22.09	-28.4	-12.25	-30.63

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Accounts Receivable Turnover	13.33	13.69	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	27.37	26.66	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.08	5.19	0.45	0.42	0.46
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4,380	70.37	810.07	863.94	785.23
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4,380	-70.37	-810.07	-863.94	-785.23
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Market Capitalization	209	162	157	236	1,662	666	826	387	68	103	67	55	136	201	50
- Cash & Cash Equivalents	17	16	20	24	176	68	307	188	74	35	49	22	29	81	38
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	38	- -	7	15	20	20	6	- -	2	23	1	1
Enterprise Value	82	32	57	158	1,336	459	508	162	-4	51	9	15	126	121	12
Total Capital	120	90	49	53	310	208	225	119	102	54	52	10	- -	23	-18
Total Debt/Capital (%)	0.01	0.01	- -	70.87	- -	3.21	6.87	16.87	19.2	11.17	- -	22.99	4,744.24	6.24	-5.06
Total Debt / EV	- -	- -	- -	0.24	- -	0.01	0.03	0.12	-4.39	0.12	- -	0.16	0.19	0.01	0.07
EV/Sales	0.98	0.63	0.8	1.71	28.37	- -	3.08	1.48	- -	8.57	0.39	4.81	73.14	65.29	4.72
EV/EBITDA	3.89	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	4.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	3.99	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	3.95	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	166	162	156	235	1,110	662	820	385	67	103	65	55	127	193	50
Diluted Enterprise Value	149	146	136	249	934	601	528	217	13	74	17	35	122	113	12
EV per Share	3.14	1.22	2.15	5.93	28.14	9.51	10.4	3.28	- -	1.01	0.15	0.26	1.95	1.36	0.14
TTM Sales	83	51	71	93	47	- -	165	109	19	6	22	3	2	2	3
TTM EBITDA	21	-44	-46	-36	-98	-126	-6	-125	-140	-35	-12	-45	-38	-45	-44
TTM Operating Income	19	-47	-48	-39	-99	-128	-8	-127	-143	-36	-12	-46	-38	-45	-45
TTM Cash Flow to Firm	-10	-3	-25	-31	-78	-114	127	-82	-153	-36	-5	-39	-33	-40	-42
TTM Free Cash Flow to Firm	-9	-1	-23	-30	-77	-112	129	-76	-152	-36	-5	-37	-33	-40	-42

Multiples (USD)

Valuation Multiples API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Price/Free Cash Flow	-18.37	-72.63	-6.34	-7.45	-14.08	-5.9	6.89	-4.99	-0.44	-2.8	-13.87	-1.4	-3.55	-4.74	-1.17
EV/EBIT	4.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	82	32	57	158	1,336	459	508	162	-4	51	9	15	126	121	12
Low Price	3.74	4.77	4.42	5.23	5.5	11.57	8.4	7.19	0.84	0.93	1	0.82	0.6	1.48	0.44
EV/Sales	0.98	0.63	0.8	1.71	28.37	- -	3.08	1.48	- -	8.57	0.39	4.81	73.14	65.29	4.72
EV/EBITDA	3.89	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	6.84	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	6.2	-5.66	-3.28	-4.69	-9.49	-9.73	-35.06	-4.37	-5.58	-2.33	-9.88	-1.67	-1.77	-5.71	-1.96
Price/Earnings High	8.27	-7.53	-4.28	-6.93	-20.76	-19.1	-50.89	-6.66	-13.45	-4.64	-14.38	-2.36	-4.63	-11.31	-4.85
Price/Earnings Low	3.2	-4	-2.38	-3.48	-3.23	-4.37	-23.42	-2.75	-1.38	-1.12	-4.92	-0.99	-0.89	-2.8	-0.89
Price/Book Value	1.74	1.8	3.18	15.31	5.36	3.31	3.94	3.93	0.82	2.16	1.28	7.09	-5.93	9.3	-2.6
Price/Book Value Average	1.57	1.96	3.28	12.22	2.47	6.17	2.93	5.72	2.07	2.05	2.18	10.21	-3.35	12.48	-4.57
Price/Book Value High	2.1	2.61	4.27	18.04	5.41	12.1	4.26	8.71	4.99	4.08	3.17	14.41	-8.76	24.72	-11.31
Price/Book Value Low	0.81	1.39	2.37	9.06	0.84	2.77	1.96	3.6	0.51	0.98	1.08	6.06	-1.68	6.12	-2.08
Price/Tangible Book Value	1.74	1.8	3.18	15.31	5.36	3.31	3.94	3.93	0.82	2.16	1.28	7.09	-5.93	9.3	-2.6
Price/Tangible Book Value Average	1.57	1.96	3.28	12.22	2.47	6.17	2.93	5.72	2.07	2.05	2.18	10.21	-3.35	12.48	-4.57
Price/Tangible Book Value High	2.1	2.61	4.27	18.04	5.41	12.1	4.26	8.71	4.99	4.08	3.17	14.41	-8.76	24.72	-11.31
Price/Tangible Book Value Low	0.81	1.39	2.37	9.06	0.84	2.77	1.96	3.6	0.51	0.98	1.08	6.06	-1.68	6.12	-2.08
Price/Sales	1.94	3.19	2.19	2.54	23.56	- -	4.97	3.53	3.58	17.11	2.95	17.94	73.82	103.66	19.1
Price/Sales Average	1.76	3.48	2.26	2.03	10.87	- -	3.7	5.15	8.97	16.22	5.02	25.82	41.73	139.08	33.5
Price/Sales High	2.35	4.64	2.94	2.99	23.77	- -	5.37	7.84	21.62	32.36	7.31	36.44	108.99	275.5	82.95
Price/Sales Low	0.91	2.46	1.63	1.5	3.7	- -	2.47	3.24	2.23	7.8	2.5	15.33	20.89	68.18	15.29
Price/Cash Flow	-15.51	-34.04	-5.87	-7.11	-13.85	-5.81	6.97	-4.61	-0.43	-2.8	-13.87	-1.32	-3.55	-4.74	-1.17
Price/Cash Flow Average	-14.07	-37.19	-6.05	-5.68	-6.39	-10.83	5.19	-6.71	-1.09	-2.65	-23.59	-1.9	-2.01	-6.36	-2.05
Price/Cash Flow High	-18.78	-49.51	-7.88	-8.38	-13.98	-21.26	7.53	-10.22	-2.62	-5.29	-34.32	-2.68	-5.24	-12.6	-5.07
Price/Cash Flow Low	-7.26	-26.27	-4.38	-4.21	-2.18	-4.87	3.47	-4.22	-0.27	-1.27	-11.75	-1.13	-1	-3.12	-0.93
Price/Free Cash Flow Average	-16.66	-79.35	-6.53	-5.95	-6.5	-11	5.13	-7.27	-1.09	-2.65	-23.59	-2.01	-2.01	-6.36	-2.05
Price/Free Cash Flow High	-22.24	-105.65	-8.5	-8.79	-14.21	-21.59	7.44	-11.07	-2.63	-5.29	-34.32	-2.83	-5.25	-12.61	-5.07
Price/Free Cash Flow Low	-8.6	-56.06	-4.72	-4.41	-2.21	-4.95	3.43	-4.57	-0.27	-1.28	-11.75	-1.19	-1.01	-3.12	-0.93
EV/Sales Average	2.07	3.17	1.99	2.18	12.56	- -	1.96	3.63	6.2	11.51	2.96	19.32	41.87	102.18	19.14
EV/Sales High	2.83	4.33	2.67	3.15	31.88	- -	3.64	6.33	19.05	27.72	5.31	29.96	114.14	244.27	68.68
EV/Sales Low	0.97	2.14	1.36	1.65	1.81	- -	0.72	1.71	- -	3.06	0.37	8.81	19.48	28.34	0.89
EV/EBITDA Average	8.18	-3.62	-3.08	-5.55	-6.07	-9.37	-52.47	-3.17	-0.83	-1.99	-5.59	-1.3	-1.89	-4.26	-1.12
EV/EBITDA High	11.19	-4.95	-4.14	-8.01	-15.4	-18.87	-97.58	-5.53	-2.55	-4.79	-10.01	-2.01	-5.16	-10.18	-4.01
EV/EBITDA Low	3.85	-2.45	-2.1	-4.2	-0.88	-3.95	-19.29	-1.49	0.09	-0.53	-0.71	-0.59	-0.88	-1.18	-0.05
EV/EBIT Average	9.03	-3.46	-2.94	-5.24	-5.96	-9.24	-40.73	-3.11	-0.81	-1.9	-5.5	-1.29	-1.87	-4.21	-1.11
EV/EBIT High	12.34	-4.72	-3.95	-7.57	-15.15	-18.6	-75.74	-5.43	-2.49	-4.56	-9.85	-2	-5.1	-10.07	-3.97
EV/EBIT Low	4.24	-2.34	-2.01	-3.97	-0.86	-3.89	-14.97	-1.47	0.08	-0.5	-0.7	-0.59	-0.87	-1.17	-0.05
Last Price	7.99	6.18	5.93	8.84	35	13.81	16.89	7.85	1.35	2.03	1.18	0.96	2.12	2.25	0.56
High Price	9.67	8.99	7.96	10.42	35.32	50.51	18.25	17.42	8.16	3.84	2.92	1.95	3.13	5.98	2.41
Enterprise Value Average	173	161	142	202	592	1,180	323	396	116	69	66	59	72	190	50
Enterprise Value High	236	220	191	292	1,502	2,375	600	691	357	166	118	91	196	454	178
Enterprise Value Low	81	109	97	153	86	497	119	186	-12	18	8	27	33	53	2

Shares Outstanding	26	26	27	27	47	48	49	49	50	51	57	57	64	89	89
Diluted Weighted Avg Shares	21	26	26	27	32	48	49	49	50	51	55	57	60	86	89
Basic Weighted Avg Shares	20	26	26	27	32	48	49	49	50	51	55	57	60	86	89
Revenue per Share	4.12	1.94	2.71	3.49	1.49	- -	3.4	2.22	0.38	0.12	0.4	0.05	0.03	0.02	0.03
EBITDA per Share	1.04	-1.69	-1.75	-1.37	-3.08	-2.63	-0.13	-2.54	-2.82	-0.69	-0.21	-0.8	-0.64	-0.52	-0.5
Operating Income per Share	0.95	-1.78	-1.83	-1.45	-3.13	-2.66	-0.16	-2.59	-2.88	-0.72	-0.22	-0.8	-0.64	-0.53	-0.5
Basic EPS, GAAP	1.17	-1.19	-1.86	-1.5	-1.7	-2.64	-0.36	-2.62	-0.61	-0.83	-0.2	-0.83	-0.68	-0.53	-0.5
Basic EPS from Cont Ops	1.17	-1.19	-1.86	-1.5	-1.7	-2.64	-0.36	-2.62	-0.61	-0.83	-0.2	-0.83	-0.68	-0.53	-0.5
Diluted EPS, GAAP	1.14	-1.19	-1.86	-1.5	-1.7	-2.64	-0.36	-2.62	-0.61	-0.83	-0.2	-0.83	-0.68	-0.53	-0.5
Diluted EPS from Cont Ops	1.14	-1.19	-1.86	-1.5	-1.7	-2.64	-0.36	-2.62	-0.61	-0.83	-0.2	-0.83	-0.68	-0.53	-0.5
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.52	-0.18	-1.01	-1.24	-2.53	-2.38	2.42	-1.7	-3.11	-0.73	-0.09	-0.73	-0.6	-0.47	-0.48
Free Cash Flow per Basic Share	-0.58	-0.28	-1.08	-1.3	-2.57	-2.41	2.4	-1.84	-3.12	-0.73	-0.09	-0.77	-0.6	-0.47	-0.48
Cash & Equivalents per Share	4.85	4.96	3.78	4.31	6.86	4.43	6.81	4.97	1.83	1.13	1.03	0.74	0.53	0.91	0.43
Book Value per Share	4.6	3.44	1.87	0.58	6.53	4.17	4.29	2	1.64	0.94	0.92	0.14	-0.36	0.24	-0.21
Tangible Book Value per Share	4.6	3.44	1.87	0.58	6.53	4.17	4.29	2	1.64	0.94	0.92	0.14	-0.36	0.24	-0.21

Infinity Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)